$SPDR标普生物科技ETF (XBI.US)$ The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023. As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
全力買い : 你有生物推荐吗?
70927684 : 做吧!!!
70927684 : 让我们走吧混蛋们!给我点些!!!